William Strohl - 04 Apr 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Reporting relationship: Director
Issuer ticker: IGMS
Reported as of: 04 Apr 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Apr 2023, 21:44:40 UTC
Prior SEC filing: 15 Mar 2022
Next SEC filing: 14 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Fred Schwarzer, by power of attorney

Filing notes and source

Key filing fact

William Strohl filed Form 4 for IGM Biosciences, Inc. (IGMS) on 06 Apr 2023.

Key facts

This page summarizes William Strohl's Form 4 filing for IGM Biosciences, Inc. (IGMS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Apr 2023, 21:44.

Change

Previous filing in this sequence was filed on 15 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IGMS transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +15,500
Change %
Price: $0.000000
Shares after: 15,500
Date: 04 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,500
Exercise price: $12.86
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1/12 of the shares subject to the option shall vest each month following the Issuer's 2023 Annual Meeting of Stockholders on the same day of the month, subject to Reporting Person remaining a Service Provider through each such date. Notwithstanding the foregoing, the shares subject to the option will be fully vested no later than the date of the Issuer's 2024 Annual Meeting of Stockholders.